Insider Transactions in Q3 2024 at Volitionrx LTD (VNRX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Ethel Rubin |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 28
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,604
-4.95%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,230
-1.82%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,158
-3.04%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Nicholas Plummer GC, Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,497
-0.92%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,950
-1.37%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,824
-2.97%
|
$0
$0.58 P/Share
|
|
Sep 01
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,671
+3.81%
|
-
|
|
Sep 01
2024
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
12,043
+6.87%
|
-
|
|
Sep 01
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
18,342
+4.14%
|
-
|
|
Sep 01
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,837
+11.71%
|
-
|
|
Sep 01
2024
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
15,668
+9.41%
|
-
|
|
Sep 01
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,784
+7.65%
|
-
|
|
Sep 01
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,240
+5.92%
|
-
|
|
Sep 01
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
9,171
+11.9%
|
-
|
|
Sep 01
2024
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
9,171
+14.21%
|
-
|
|
Sep 01
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,258
+10.05%
|
-
|
|
Sep 01
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
35,783
+11.06%
|
-
|
|
Sep 01
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,493
+3.58%
|
-
|
|
Sep 01
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,731
+10.81%
|
-
|
|
Sep 01
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
13,757
+5.95%
|
-
|
|
Sep 01
2024
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
103,243
+4.96%
|
-
|
|
Aug 20
2024
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
150,000
+26.95%
|
$0
$0.67 P/Share
|
|
Aug 15
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,250
+6.24%
|
-
|
|
Aug 15
2024
|
Mickie Henshall |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+13.44%
|
-
|
|
Aug 15
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+5.28%
|
-
|
|
Aug 15
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+2.39%
|
-
|
|
Aug 15
2024
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,500
+1.55%
|
-
|
|
Aug 15
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+4.21%
|
-
|
|
Aug 15
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+7.78%
|
-
|
|
Aug 15
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+8.31%
|
-
|
|
Aug 15
2024
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
16,750
+11.02%
|
-
|
|
Aug 15
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,250
+9.1%
|
-
|
|
Aug 15
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+1.91%
|
-
|
|
Aug 15
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,250
+11.75%
|
-
|
|
Aug 15
2024
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+9.77%
|
-
|
|
Aug 15
2024
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
17,250
+10.24%
|
-
|
|
Aug 15
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.85%
|
-
|
|
Jul 04
2024
|
Guy Archibald Innes |
BUY
Bona fide gift
|
Indirect |
400,000
+22.22%
|
-
|
|
Jul 04
2024
|
Guy Archibald Innes |
SELL
Bona fide gift
|
Direct |
400,000
-61.38%
|
-
|